| Dr Thomas P Olenginski, MD | |
|
100 N Academy Ave, Danville, PA 17822-1341 | |
| (570) 271-6416 | |
| (570) 271-5845 |
| Full Name | Dr Thomas P Olenginski |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 40 Years |
| Location | 100 N Academy Ave, Danville, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720041676 | NPI | - | NPPES |
| 001123506 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD033847E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Geisinger Medical Center | Danville, PA | Hospital |
| Geisinger-bloomsburg Hospital | Bloomsburg, PA | Hospital |
| Evangelical Community Hospital | Lewisburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Geisinger Clinic | 5395657001 | 2866 |
News Archive
By analyzing throat and nose swabs from patients in Southern California, researchers detected a new SARS-CoV-2 strain with mutations in the spike protein. This major finding may explain a surge in the number of cases in the region.
In a study published online today in Science Translational Medicine, Albert Einstein College of Medicine researchers report that an experimental peptide drug shows promise against the often-lethal cancer acute myeloid leukemia and describe how the drug works at the molecular level.
In an interview with President Barack Obama, The National Journal asked about the GOP agenda, including repealing the health law. What is clear to me is that in the abstract, everybody on the Republican side is for repeal, Obama said.
Like horses running down the long stretch of a race track, two different artery-opening treatments appear to be running neck-and-neck when it comes to preventing stroke among people with clogged neck arteries and other health problems.
Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.
› Verified 7 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366493868 PECOS PAC ID: 5395657001 Enrollment ID: O20040130000518 |
News Archive
By analyzing throat and nose swabs from patients in Southern California, researchers detected a new SARS-CoV-2 strain with mutations in the spike protein. This major finding may explain a surge in the number of cases in the region.
In a study published online today in Science Translational Medicine, Albert Einstein College of Medicine researchers report that an experimental peptide drug shows promise against the often-lethal cancer acute myeloid leukemia and describe how the drug works at the molecular level.
In an interview with President Barack Obama, The National Journal asked about the GOP agenda, including repealing the health law. What is clear to me is that in the abstract, everybody on the Republican side is for repeal, Obama said.
Like horses running down the long stretch of a race track, two different artery-opening treatments appear to be running neck-and-neck when it comes to preventing stroke among people with clogged neck arteries and other health problems.
Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.
› Verified 7 days ago
| Entity Name | Geisinger-hm Joint Venture Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144876137 PECOS PAC ID: 1355676370 Enrollment ID: O20190826000803 |
News Archive
By analyzing throat and nose swabs from patients in Southern California, researchers detected a new SARS-CoV-2 strain with mutations in the spike protein. This major finding may explain a surge in the number of cases in the region.
In a study published online today in Science Translational Medicine, Albert Einstein College of Medicine researchers report that an experimental peptide drug shows promise against the often-lethal cancer acute myeloid leukemia and describe how the drug works at the molecular level.
In an interview with President Barack Obama, The National Journal asked about the GOP agenda, including repealing the health law. What is clear to me is that in the abstract, everybody on the Republican side is for repeal, Obama said.
Like horses running down the long stretch of a race track, two different artery-opening treatments appear to be running neck-and-neck when it comes to preventing stroke among people with clogged neck arteries and other health problems.
Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas P Olenginski, MD 100 N Academy Ave, Danville, PA 17822-3034 Ph: (570) 271-6144 | Dr Thomas P Olenginski, MD 100 N Academy Ave, Danville, PA 17822-1341 Ph: (570) 271-6416 |
News Archive
By analyzing throat and nose swabs from patients in Southern California, researchers detected a new SARS-CoV-2 strain with mutations in the spike protein. This major finding may explain a surge in the number of cases in the region.
In a study published online today in Science Translational Medicine, Albert Einstein College of Medicine researchers report that an experimental peptide drug shows promise against the often-lethal cancer acute myeloid leukemia and describe how the drug works at the molecular level.
In an interview with President Barack Obama, The National Journal asked about the GOP agenda, including repealing the health law. What is clear to me is that in the abstract, everybody on the Republican side is for repeal, Obama said.
Like horses running down the long stretch of a race track, two different artery-opening treatments appear to be running neck-and-neck when it comes to preventing stroke among people with clogged neck arteries and other health problems.
Soligenix, Inc., a late-stage biopharmaceutical company, today announced that it has entered into a definitive license agreement with the University of Colorado (CU) for novel technology for use in the development of subunit vaccines with long-term stability, including stability at elevated temperatures.
› Verified 7 days ago
Dr. Stanley Joseph Russin, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-214-9585 Fax: 570-214-9519 | |
Dr. Steven Bonebrake, D.O. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-5555 Fax: 570-271-5269 | |
Tatiana Parra, Rheumatology Medicare: Medicare Enrolled Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6164 Fax: 570-271-6141 | |
Dr. Paul Flavian Simonelli, MD, PH.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Mc 01-11, Danville, PA 17822 Phone: 570-271-6655 Fax: 570-214-3967 | |
Dr. Taher M. Yahya, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6393 Fax: 570-271-5623 | |
Dr. Ion D. Bucaloiu, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6164 Fax: 570-271-6141 | |
Dr. Mark A Shelly, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6408 Fax: 570-271-5845 |